Cutting-edge NHS drugs do more harm than good

Almost all new drugs approved for NHS use do more harm than good, according to modelling adopted by the government. The Department of Health and Social Care has implicitly conceded that the cost of most cutting-edge medicines kills more people through diverting money from other NHS services than the treatments themselves save. Yet drugs are still assessed using a more generous formula than other types of NHS spending and experts have questioned why they are prioritised over areas such as nursing staff or radiotherapy machines to treat cancer.
The Times